Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) September 12 - 13, 2025!

For more Information and Register: Delaware ACC By the Sea: 2025 Chapter Meeting

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

Poll: Transcatheter Mitral Valve Replacement in a High Surgical Risk Patient With Mitral Stenosis
Mrs. M is an 81-year-old female patient who presents with worsening exertional dyspnea. She has a history of type 2 diabetes mellitus, heart failure with preserved ejection fraction, and prior surgical aortic valve replacement in the setting of severe symptomatic aortic stenosis.
PRAGUE-25: What Is the Best Intervention Strategy For AFib In Obesity?
Catheter ablation (CA) was superior to a combination of lifestyle modification (LFM) and antiarrhythmic drugs (AADs) in improving freedom from atrial fibrillation (AFib) at one year in patients with obesity, according to results from the PRAGUE-25 trial published in JACC.
June AMA House of Delegates Key Takeaways
The American Medical Association (AMA) House of Delegates met in June to discuss and vote on the latest round of proposed resolutions aimed at guiding AMAâ€™s policies on key medical, ethical and public health issues.
SWISS-APERO: Similar 3-Year Ischemic Risk With Amulet vs. Watchman FLX
While there was no significant difference in ischemic risk in patients with atrial fibrillation between the Amulet and Watchman FLX devices at three years following left atrial appendage closure (LAAC), according to findings from the SWISS-APERO trial published in JACC...
ACCEL Lite: Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF
In this interview, Drs. Matthew Martinez and Barry Borlaug discuss â€œHemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF.â€